rbs morgans say buy, page-3

This is an extract from the RBS Morgans research giving the milestone planned timeline and their relative thoughts of their effectiveness if achieved.

This information will be available from the TIS web site but just encapsulates it well.

Regards...........

Table 1 : Milestone table
Expected date Milestone Expected catalyst
Jul-11 Interim results EU multicentre venous ulcer trial ? full results
in Sept
Positive
3QCY11 (was 2QCY11) Formal FDA request for designation as a device Positive
4QCY11 Regulatory approval for sale: starting for Rest of World Positive
1QCY12 Approval for sale in EU Very Positive
2QCY12 Sales launch in EU Very Positive
3QCY12 Venous ulcer clinical trial completed in US Positive
3QCY12 World-wide launch outside EU and US: starting for Rest
of World
Positive
2QCY13 Approval VitroGro? for treatment of venous ulcers Very Positive
3QCY13 US launch of VitroGro? for treatment of venous ulcers Very Positive
2QCY13 Diabetic and pressure ulcer clinical trials completed in US Positive
4QCY13 Approval of VitroGro? for treatment of diabetic and pressure


ulcers in US
Very Positive
1QCY14 US launch of VitroGro? for treatment of diabetic and pressure
ulcers
Positive
Source: Company data, RBS Morgans forecasts